Carl Hull compensation by year
MARAVAI LIFESCIENCES Summary Compensation Table · all 5 fiscal years held| Component | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Salary | $485,417 | $500,000 | $580,769 | $721,383 | $617,668 |
| Bonus | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $0 | $0 | $0 | $2,147,712 | $2,291,342 |
| Option awards | $1,743,000 | $874,160 | $0 | $1,879,416 | $2,308,003 |
| Non-equity incentive | $600,000 | $750,000 | $1,200,000 | $732,290 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 |
| All other | $0 | $0 | $0 | $0 | $0 |
| Total | $2,828,417 | $2,124,160 | $1,780,769 | $5,480,801 | $5,217,013 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MARAVAI LIFESCIENCES HOLDINGS, INC. DEF 14A filed April 25, 2024, accession 0001193125-24-114058, and prior-year filings. Open the filing on EDGAR.
How this page was built: the MARAVAI LIFESCIENCES HOLDINGS, INC. filed document, accession 0001193125-24-114058. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2024.
Equity holdings
unvested awards at FY2023 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 147,638 | $967,029 | — |
| RSU | 54,400 | $356,320 | — |
| Option | 219,464 | — | $15.52 |
| Option | 13,750 | — | $27.00 |
| Option | 81,900 | — | $26.32 |
Per the Outstanding Equity Awards at Fiscal Year-End table in MARAVAI LIFESCIENCES HOLDINGS, INC.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.
MARAVAI LIFESCIENCES’s named executive officers, FY2023
as the company reported each| Named executive officer | Role | FY2023 total |
|---|---|---|
| Carl Hull · this page | Executive Chairman and Former Interim Chief Executive Officer | $5,217,013 |
| Andrew Burch | President, Nucleic Acid Production | $2,992,807 |
| Peter Leddy | Chief Administrative Officer | $2,827,776 |
| Kevin Herde | Chief Financial Officer | $2,793,002 |
| William Martin | Chief Executive Officer | $2,301,864 |
| Christine Dolan | General Manager, Cygnus Technologies | $2,263,082 |
Board service
MARAVAI LIFESCIENCES board · FY2021How this board is paid
Company policy: MARAVAI LIFESCIENCES pays directors a $40,000 cash retainer and $160,000 in RSUs. As stated in MARAVAI LIFESCIENCES's FY2021 proxy.
The full MARAVAI LIFESCIENCES compensation record
free company briefThis page is one person within MARAVAI LIFESCIENCES's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the MARAVAI LIFESCIENCES proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are MARAVAI LIFESCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.